{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T22:53:40Z","timestamp":1781304820072,"version":"3.54.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Early detection of neuropsychiatric systemic lupus erythematosus (NPSLE) remains a challenge in clinical settings. Previous studies have found different autoantibodies as markers for NPSLE. This study aimed to describe the distribution of psychiatric syndromes in a group of patients with systemic lupus erythematosus (SLE) and to investigate the association between psychiatric syndromes and specific autoantibodies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective study was conducted at a single medical center in China. We reviewed medical records of hospitalized patients with SLE who were consulted by psychiatrists due to potential mental disorders. Results of serum autoantibodies and general laboratory tests were collected. The correlation between clinical variables was examined. Binary logistic regression analyses were used to determine factors related to NPSLE and different psychiatric diagnoses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 171 psychiatric manifestations in 160 patients, 141 (82.4%) were attributed to SLE. Acute confusional state (ACS) had the highest prevalence (57.4%). Anti-cardiolipin (ACL) antibody (<jats:italic>X<\/jats:italic><jats:sup>2\u00a0=\u00a0<\/jats:sup>142.261, p &amp;lt; 0.001) and anti-\u03b22 glycoprotein I (-\u03b22GP1) antibody (<jats:italic>X<\/jats:italic><jats:sup>2\u00a0=\u00a0<\/jats:sup>139.818, p &amp;lt; 0.001) varied significantly between groups, with the highest positive rate found in patients with mood disorders (27.3% and 18.2%). SLE disease activity index \u2013 2000 (SLEDAI-2K) score excluding item ACS and item psychosis was a predictor of NPSLE (OR 1.172 [95% CI 1.105 - 1.243]).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Disease activity reflected by SLEDAI-2K score is a predictor for NPSLE. Antiphospholipid antibodies are associated with mood disorders in SLE. Further separate investigation of neuropsychiatric disorders is needed in order to better comprehend NPSLE\u2019s pathological mechanism.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1323209","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T04:54:27Z","timestamp":1710996867000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Predictive factors of psychiatric syndrome in patients with systemic lupus erythematosus"],"prefix":"10.3389","volume":"15","author":[{"given":"Wenqi","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangzhu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinya","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216150","article-title":"Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach","volume":"79","author":"Hanly","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jaut.2016.06.013","article-title":"The diagnosis and clinical management of the neuropsychiatric manifestations of lupus","volume":"74","author":"Govoni","year":"2016","journal-title":"J Autoimmun"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.15","article-title":"Diagnosis and management of neuropsychiatric SLE","volume":"10","author":"Hanly","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2010.62","article-title":"Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations","volume":"6","author":"Bertsias","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102780","article-title":"Neuropsychiatric involvement in systemic lupus erythematosus: A review","volume":"20","author":"Carri\u00f3n-Barber\u00e0","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/(ISSN)1529-0131","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"key":"B7","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/wnl.57.3.496","article-title":"The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus","volume":"57","author":"Ainiala","year":"2001","journal-title":"Neurology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015546","article-title":"Validity of the Italian algorithm for the attribution of neuropsychiatric events in systemic lupus erythematosus: a retrospective multicentre international diagnostic cohort study","volume":"7","author":"Bortoluzzi","year":"2017","journal-title":"BMJ Open"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/art.40930","article-title":"2019 european league against rheumatism\/american college of rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol (Hoboken N.J.)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-018-0156-8","article-title":"Neuropsychiatric lupus: new mechanistic insights and future treatment directions","volume":"15","author":"Schwartz","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0534-3","article-title":"Management of neuropsychiatric systemic lupus erythematosus: current approaches and future perspectives","volume":"76","author":"Magro-Checa","year":"2016","journal-title":"Drugs"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.10.003","article-title":"A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus","volume":"15","author":"Ho","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1177\/09612033231151600","article-title":"The pathogenic role of lupus-specific autoantibodies and Interleukin-6 on demyelination of the brainstem and spinal cord in systemic lupus erythematosus","volume":"32","author":"Hasegawa","year":"2023","journal-title":"Lupus"},{"key":"B14","article-title":"Role of serum autoantibodies in blood brain barrier damages in neuropsychiatric systemic lupus erythematosus","volume":"36","author":"Hirohata","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.03.011","article-title":"Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort","volume":"42","author":"Borowoy","year":"2012","journal-title":"Semin Arthritis rheumatism"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1157149","article-title":"Brainreactive autoantibodies in neuropsychiatric systemic lupus erythematosus","volume":"14","author":"Cocco","year":"2023","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheumatol"},{"key":"B18","volume-title":"The ICD-10 classification of mental and behavioural disorders","year":"1993"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B20","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrneurol.2014.148","article-title":"Neuropsychiatric systemic lupus erythematosus pathogenesis and biomarkers","volume":"10","author":"H\u00e9l\u00e8ne Jeltsch-David","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00138","article-title":"Definition of NPSLE: does the ACR nomenclature still hold","volume":"5","author":"Vivaldo","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.5606\/ArchRheumatol.2019.6981","article-title":"The predictive value of autoantibody spectrum on organ damage in patients with systemic lupus erythematosus","volume":"34","author":"Yuan","year":"2018","journal-title":"Arch Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1128\/CVI.13.1.77-83.2006","article-title":"International multicenter evaluation of autoantibodies to ribosomal P proteins","author":"Mahler","year":"2006","journal-title":"Clin Vaccine Immunol CVI"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-06034-6","article-title":"The role of anti-ribosomal P autoantibodies in the prediction of neuropsychiatric damage in systemic lupus erythematosus based on CSTAR cohort (XIV)","volume":"41","author":"Ding","year":"2022","journal-title":"Clin Rheumatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2023-001005","article-title":"The effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study","volume":"10","author":"Chessa","year":"2023","journal-title":"Lupus Sci Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2022-000668","article-title":"Role of autoantibodies and blood-brain barrier leakage in cognitive impairment in systemic lupus erythematosus","volume":"9","author":"Hanly","year":"2022","journal-title":"Lupus Sci Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21691","article-title":"Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus","volume":"64","author":"Murray","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1756193","article-title":"Antiphospholipid antibodies in pregnancy: maternal and neonatal implications","volume":"49","author":"Gris","year":"2023","journal-title":"Semin Thromb Hemost"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2012.01024.x","article-title":"Neuroprogression in bipolar disorder","volume":"14","author":"Schneider","year":"2012","journal-title":"Bipolar Disord"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.080697","article-title":"Neurobiological mechanisms in major depressive disorder","volume":"180","author":"aan het Rot","year":"2009","journal-title":"CMAJ"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2013.20","article-title":"The vascular depression hypothesis: mechanisms linking vascular disease with depression","volume":"18","author":"Taylor","year":"2013","journal-title":"Mol Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2018.08.040","article-title":"Cerebral blood flow in bipolar disorder: A systematic review","volume":"241","author":"Toma","year":"2018","journal-title":"J Affect Disord"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1323209\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T04:54:32Z","timestamp":1710996872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1323209\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":34,"alternative-id":["10.3389\/fimmu.2024.1323209"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1323209","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"article-number":"1323209"}}